Lysins: the arrival of pathogen-directed anti-infectives.
about
Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New AntimicrobialsAntimicrobial bacteriophage-derived proteins and therapeutic applicationsPlant-based solutions for veterinary immunotherapeutics and prophylacticsBacteriophages and phage-derived proteins--application approachesThe global threat of antimicrobial resistance: science for interventionEngineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogensGMEnzy: a genetically modified enzybiotic databaseAntibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosaArt-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosaPhage therapy--constraints and possibilities.Bioengineered lysozyme in combination therapies for Pseudomonas aeruginosa lung infectionsComplete Genome Sequence of Bacillus cereus Sensu Lato Bacteriophage Bcp1.Panel 4: Report of the Microbiology Panel.Bacteriophage-based synthetic biology for the study of infectious diseases.Engineered bacteriophage lysins as novel anti-infectivesWhole-genome sequence assembly of Pediococcus pentosaceus LI05 (CGMCC 7049) from the human gastrointestinal tract and comparative analysis with representative sequences from three food-borne strains.Lysibodies are IgG Fc fusions with lysin binding domains targeting Staphylococcus aureus wall carbohydrates for effective phagocytosis.Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model.Genetically enhanced lysozyme evades a pathogen derived inhibitory protein.Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent.Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance.A Thermophilic Phage Endolysin Fusion to a Clostridium perfringens-Specific Cell Wall Binding Domain Creates an Anti-Clostridium Antimicrobial with Improved Thermostability.Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity.Mycobacteriophage cell binding proteins for the capture of mycobacteria.RETRACTED: Identification of Peptidoglycan Hydrolase Constructs with Synergistic Staphylolytic Activity in Cow's Milk.A bacteriophage endolysin that eliminates intracellular streptococciPL3 Amidase, a Tailor-made Lysin Constructed by Domain Shuffling with Potent Killing Activity against Pneumococci and Related SpeciesNovel giant siphovirus from Bacillus anthracis features unusual genome characteristics.A novel chimeric lysin with robust antibacterial activity against planktonic and biofilm methicillin-resistant Staphylococcus aureus.Molecular dissection of phage endolysin: an interdomain interaction confers host specificity in Lysin A of Mycobacterium phage D29.New perspectives in the management of Pseudomonas aeruginosa infections.Phage lytic proteins: biotechnological applications beyond clinical antimicrobials.Bacteriophage therapy against Enterobacteriaceae.Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial)Bacteriophage Lysin CF-301, a Potent Antistaphylococcal Biofilm Agent.Modeling intraocular bacterial infections.The Vibrio parahaemolyticus-infecting bacteriophage qdvp001: genome sequence and endolysin with a modular structure.Characterization and complete genome sequence analysis of a novel virulent Siphoviridae phage against Staphylococcus aureus isolated from bovine mastitis in Xinjiang, China.Recent advances in therapeutic delivery systems of bacteriophage and bacteriophage-encoded endolysins.Models for the directed evolution of bacterial allelopathy: bacteriophage lysins.
P2860
Q26744448-CEEDE176-A6BC-4B3F-BB34-F3A95EE29ED4Q26781115-EC210704-0F50-4693-BCE5-F1DA1E3D99B4Q27000876-FC2942F9-4EBD-4C29-B30D-01EEE67AD51BQ28082731-CA3B0BCC-9B73-43CD-BEF3-33064C1A6F7FQ28083609-55CABF0C-A6AB-4A7C-9375-0ADA5B58689BQ28243174-8E14606F-65B8-4837-A3A7-C51E064CADB9Q28541518-3F023260-49C8-48F6-B360-35BBEE4D9341Q28603769-0DFB5B01-4060-4B7E-8C2E-F9DFA04E7EA1Q30581467-80B652FB-0E87-4535-9940-6979433C6692Q33667556-C3ACA4FD-3937-47BE-82E6-48F56F90746CQ33728266-E771ECFE-9B9B-4E8E-9FE4-2321EBEE3336Q33750901-2D7C8900-1BE9-481F-AEA6-F15B00A5ADB7Q33851484-92310F96-76BF-4AFE-BB51-3C8ED205893EQ34017160-879F0FF7-52AE-4F8A-BEBE-9DA34EF6A279Q34349552-597ED2BE-9471-4B90-92F3-C2A99708C897Q34404919-0E6CB43E-D7E7-41BB-B3CB-E44E11FECD45Q34555552-5E6B6ECA-A9CC-49ED-99A6-12FD11024E60Q35168859-D9B1F167-7178-47C6-A971-AFD8A003CF10Q35546372-17A7E158-EB7A-4FA1-AC4E-DAED85646053Q35653429-27F9C55C-5D1D-4284-866C-97256490B77AQ35751036-7ECC863E-071E-4BC5-A531-44331D9E599AQ35808669-6D2CE4DB-2C02-4173-9811-49E16F31F8F4Q35842148-B29BABB2-7D91-4A1C-8CC0-5A7F7E02C4E8Q36110304-78A0D2BE-8175-4DBA-BF00-F0628C74B718Q36270490-C6F5D324-2905-4AA4-A72A-1439DB808B64Q36844603-1A1E1B05-B895-41C1-B4EF-89874E312378Q37131742-BD84E49B-37E3-4D91-AF92-237C0745D527Q37520648-A8547A3D-45AD-429C-9B71-34970A7C7BEBQ37571286-FD928F78-AA21-4E25-AE2E-B881088A5C29Q37727646-93DCF52B-27E4-4632-A5E2-7D5D2E2E80CDQ38243221-F5F6FA9A-FAF0-4585-85A5-8E6B595F69A1Q38325227-12FE9BC6-8E52-4914-841F-CC7220999DE8Q38348303-63DE750E-735A-43CF-8C17-4C0E9E3F205DQ38599413-5BD6E862-8285-4C41-9576-E2F1F42AB52EQ38810296-8C4286B6-4892-4C2D-BF54-DACDC4C088A7Q38827899-04293936-9F73-4B09-A6DF-030B01A15B75Q38845481-FC4D579A-8674-43DF-92EF-88F027BC168EQ38904362-C6E3EA07-D4EB-4A68-B0D1-8076C25507B4Q39386520-DAF95E7F-68E4-42A9-8681-83A0E152F3B5Q39531958-5124DD30-DC68-4BC8-82A5-24E8B4D61417
P2860
Lysins: the arrival of pathogen-directed anti-infectives.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Lysins: the arrival of pathogen-directed anti-infectives.
@ast
Lysins: the arrival of pathogen-directed anti-infectives.
@en
Lysins: the arrival of pathogen-directed anti-infectives.
@nl
type
label
Lysins: the arrival of pathogen-directed anti-infectives.
@ast
Lysins: the arrival of pathogen-directed anti-infectives.
@en
Lysins: the arrival of pathogen-directed anti-infectives.
@nl
prefLabel
Lysins: the arrival of pathogen-directed anti-infectives.
@ast
Lysins: the arrival of pathogen-directed anti-infectives.
@en
Lysins: the arrival of pathogen-directed anti-infectives.
@nl
P2093
P356
P1476
Lysins: the arrival of pathogen-directed anti-infectives.
@en
P2093
David B Huang
Mina Pastagia
Raymond Schuch
Vincent A Fischetti
P304
P356
10.1099/JMM.0.061028-0
P577
2013-06-27T00:00:00Z